01548 GENSCRIPT BIO
- 11.020
- +0.260+2.42%
GENSCRIPT BIO News
A quick look at the Hong Kong market | Hong Kong stocks explode! The Ke Index rose nearly 5%; domestic housing stocks and auto stocks improved, Sunac China rose more than 15%, and Xiaopeng Motors rose nearly 9%
Technet stocks performed brilliantly. Kuaishou rose more than 7%, JD rose nearly 6%; biotech stocks generally rose, Tiger Pharmaceuticals rose more than 8%, and Pharmaceutical Biotech rose nearly 6%.
BOC International: Maintaining Kingsley Biotech's (01548) “Buy” Rating Target Price of HK$27.75
Kingsley Biotech (01548) guides strong annual revenue growth of 15%-20% and 20%-30% (@CER, i.e. Comparative Effects Study).
Statistics on changes in the share of Zhitong Hong Kong Stock Connect | April 24
According to data disclosed on April 23, 2024, China Alcoa International (02068.HK), Peer Hunting (06100.HK), and KEEP INC. (03650.HK) Hong Kong Stock Connect held the largest share increases of 1.87%, 0.74%, and 0.68% respectively; Huadian International Power (01071.HK), Follett Glass (06865.HK), and Kingsley Biotech (01548.HK) Hong Kong Stock Connect shares decreased the most, decreasing by -0.56% and -0.49%, respectively, -0.36% .
Kingsley Biotech (1548.HK): Approved for major indications, rapid release of CARVYKTI can be expected; focus on centralized implementation of 2H catalysts
Carvykti added second-line MM indications to focus on clinical progress in primary treatment of MM. According to Johnson & Johnson's 1Q24 report, Carvykti recorded sales of US$157 million, +118.1% YoY. 2
Kingsley Biotechnology (01548.HK): The European Commission approved CARVYKTI for second-line treatment of patients with recurrent refractory multiple myeloma
Gelonghui, April 23 | Kingsley Biotech (01548.HK) issued an announcement. On April 22, 2024, Legend Biotech issued a press release announcing that the European Commission (EC) approved CARVYKTI (ciltacabtagene autoleucel, cilta-cel) for the treatment of adult patients with recurrent and refractory multiple myeloma. These patients have received at least one treatment in the past, including proteasome inhibitors (PI) and immunomodulators (IMID). The patients showed disease progression during the last treatment , and lenalidomide is difficult to treat
金斯瑞生物科技：2023年度報告
A quick look at the Hong Kong market | The three major indices have risen one after another. Technet stocks have generally risen, Tencent and Meituan have risen by more than 5%; Ideal has fallen by more than 8%
Many coal stocks fell sharply; Mongolian coking coal and China Coal Energy fell more than 6%; petroleum stocks fell, CNOOC Services fell more than 3%, and CNPC fell nearly 3%.
Kingsley Biotechnology (1548.HK): Global layout, business blossoming, innovative drug business entering a commercialization period
Under the intertwined influence of the risk factors of globalization, how can enterprises persevere and continue to move forward in the midst of turbulence has become a common problem in the industry. However, Kingsley seemed to have given his own unique answer with an excellent questionnaire.
Hong Kong bullish stocks this week | 80% increase in the month! TCL Electronics surged more than 16% this week; CRRC surged nearly 11% the day after
Benefiting from the acceleration of nuclear power approval, CGN's stock price has been rising for five consecutive days; coal supply and demand continued to be tight, and Mongolian coking coal increased by more than 11% during the week.
Direct impact of changes | CRO concept stocks continue to decline, the Federal Reserve does not rule out the possibility of interest rate hikes, and domestic innovative drugs are still in an adjustment cycle
On April 19, $Pharmaceutical Outsourcing Concept (BK1261.HK) $ continued its decline. As of press release, $Kingsley Biotech (01548.HK) $ fell 8.55% to HK$10.48; $Tiger Pharmaceuticals (03347.HK) $ fell 5.87% to HK$29.1; $Kanglong Chemical (03759.HK) $ fell 5.62% to HK$8.40. Market source: Futubull Niu News reported that overnight, Federal Reserve officials made hawkish remarks. New York Federal Reserve Chairman Williams said that if the data reminds us that we need to raise interest rates to achieve our goals, then we will show
Hong Kong Stock Afternoon Review | The three major indices fell sharply, auto stocks fell, and Ideal Auto fell by more than 7%
Technology and network stocks generally fell; Xiaomi fell more than 4%, Meituan fell nearly 4%; shipping stocks rose higher, Pacific Shipping rose more than 9%, and COSCO Haineng rose more than 5%.
Changes in Hong Kong stocks | CRO concept stocks continue to decline, the Federal Reserve does not rule out possible interest rate hikes, domestic innovative drugs are still in an adjustment cycle
CRO concept stocks continued to decline. As of press release, Tiger Pharmaceuticals (03347.HK) fell 7.94% to HK$28.4; Kingsley Biotech (01548.HK) fell 5.93% to HK$10.78; Kanglong Chemical (03759.HK) fell 4.83% to HK$8.47; and Pharmaceuticals (02359.HK) fell 4.5% to HK$32.9.
Selected announcements | China Electric Power's Q1 electricity sales increased by more than 30%; China Coal Energy's Q1 commercial coal sales fell by about 15%
Xinhua Insurance: Q1 received an 11.7% year-on-year decrease in total premium income; Meituan spent about HK$399 million to repurchase 4 million shares.
Kingsley Biotechnology (01548.HK): CARVYKTI's net trade sales in the first quarter were about US$157 million
On April 16, 2024, Legend Biotech Co., Ltd. (LEGENDARY BIOTECH) announced that in accordance with the cooperation and licensing agreement signed by Legend Biotech, Inc. (Janssen) on December 21, 2017, CARVYKTI generated net trade sales of approximately US$157 million in the quarter ending March 31, 2024.
Liu Zhenyu sold 79,700 common shares of Kingsley Biotech (01548.HK) worth approximately HK$1.025 million
On April 16, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 16, Liu Zhenyu sold $79,700 common shares of $Kingsley Biotechnology (01548.HK) at an average price of HK$12.5795 per share on April 11, worth approximately HK$1.025 million. After the sale, Liu Zhenyu's latest shareholding was 9.426 million shares, and the good position ratio dropped from 0.45% to 0.44%. Additional Information: Dr. Liu was under restricted shares (the “RSAs”)
Hong Kong Stock Afternoon Review | The three major indices continued to weaken, the Tech Index fell nearly 3%, and Tech Net stocks and auto stocks generally fell
Biotech stocks fell collectively; Kingsley Biotech fell more than 4%; Genting Xinyao fell by more than 3%; gaming stocks fell, with Aobo Holdings and Sands China falling more than 4%; insurance stocks fell by more than 3%; and China Ping An fell nearly 2%.
Changes in Hong Kong stocks | Kingsley Biotech (01548) fell more than 5%, and the company's stock price hit a new low in recent years. CDMO short-term demand growth and profitability were under pressure
Kingsley Biotech (01548) fell by more than 5%, down 5.59% at press time, to HK$11.48, with a turnover of HK$104 million.
Hong Kong Stock Afternoon Review | The three major indices declined, TechNet stocks and gold stocks fell, NetEase fell nearly 3%, and Zhaojin Mining fell nearly 9%
Biotech stocks fell, with Genting Xinyao falling more than 6%, and Kingsley Biotech falling nearly 5%; auto stocks fell by many stocks, Xiaopeng Motors fell nearly 4% and Geely fell nearly 3%; petroleum stocks improved, and CNPC rose more than 2%.
Hong Kong Market Overview | The three major indices fell slightly. Domestic housing stocks and biotech stocks were sluggish throughout the day. Sunac China fell more than 4%, and BeiGene Shenzhou fell nearly 5%
The trend of Technology Network stocks was divided. NetEase fell more than 3% and Meituan rose slightly; auto stocks had mixed ups and downs, with ideal falling by more than 2%, and BYD rising slightly; coal stocks rose one after another, with China Coal Energy rising by nearly 3% and Yankuang Energy by more than 2%.
Hong Kong Stock Afternoon Review | The three major indices declined, TechNet stocks and biotech stocks fell, NetEase fell nearly 4%, and BeiGene Shenzhou fell more than 5%
Domestic housing stocks and property management stocks declined one after another. Sunac China fell more than 6%, Country Garden Services fell more than 3%; petroleum stocks improved, and CNOOC and CNPC rose more than 1%; many gold stocks rose, Zijin Mining rose nearly 3%, and Zhaojin Mining rose more than 1%.
Analysis
Price Target
No Data
